| |
1st
Quarter
2005 |
1st Quarter
2006 |
| EUR million |
|
|
| Operating result (EBIT) |
1,004 |
1,108 |
| Income taxes |
(221) |
(234) |
| Depreciation and amortization |
433 |
444 |
| Change in pension provisions |
(117) |
(127) |
| (Gains) losses on retirements of noncurrent assets |
2 |
(1) |
| Gross cash flow* |
1,101 |
1,190 |
| Decrease (increase) in inventories |
(231) |
(154) |
| Decrease (increase) in trade accounts receivable |
(936) |
(868) |
| Increase (decrease) in trade accounts payable |
(254) |
(234) |
| Changes in other working capital, other
non-cash items |
94 |
194 |
Net cash provided by (used in)
operating activities
(net cash flow, continuing operations) |
(226) |
128 |
Net cash provided by (used in) operating
activities
(net cash flow, discontinued operations) |
(32) |
– |
| Net cash flow provided by (used in) operating
activities (net cash flow, total) |
(258) |
128 |
| Cash outflows for additions to property, plant, equipment
and intangible assets |
(181) |
(419) |
| Cash inflows from sales of property,
plant, equipment and other assets |
256 |
20 |
| Cash inflows from sales of investments |
1,000 |
26 |
| Cash outflows for acquisitions less acquired cash |
(2,053) |
(20) |
| Interest and dividends received |
28 |
107 |
| Cash inflows from marketable securities |
3 |
94 |
| Net cash provided by (used in) investing
activities (total) |
(947) |
(192) |
| Capital contributions |
0 |
0 |
Bayer AG dividend and dividend payments to minority
stockholders/
reimbursements of advance capital gains tax payments |
(33) |
165 |
| Issuances of debt |
264 |
269 |
| Retirements of debt |
(554) |
(393) |
| Interest paid |
(107) |
(228) |
| Net cash provided by (used in) financing activities
(total) |
(430) |
(187) |
| Change in cash and cash equivalents due to
business activities (total) |
(1,635) |
(251) |
| Cash and cash equivalents at beginning of
period |
3,570 |
3,290 |
| Change in cash and cash equivalents due to changes
in scope of consolidation |
(196) |
(2) |
| Change in cash and cash equivalents due to exchange
rate movements |
10 |
(11) |
| Cash and cash equivalents at end of period |
1,749 |
3,026 |
| Marketable securities and other instruments |
34 |
137 |
| Liquid assets as per balance sheets |
1,783 |
3,163 |
top
E-mail this page
Download Acrobat Reader